Shopping Cart (0)
My Account

 Shopping Cart
Conferences | Training Courses | Market Reports | Managed Events | Past Conferences | Update Me
SELECTBIO Conferences Organ-on-a-Chip and Body-on-a-Chip: In Vitro Systems Mimicking In Vivo Functions
Conferences  \  Organ-on-a-Chip World Congress & 3D-Culture 2016  \  Organ-on-a-Chip and Body-on-a-Chip: In Vitro Systems Mimicking In Vivo Functions  \  Agenda  \  Ioannis Zervantonakis
RegisterLogin

Ioannis Zervantonakis's Biography


Ioannis Zervantonakis, Research Fellow in Cell Biology, Harvard Medical School

Dr. Zervantonakis received his undergraduate degree in mechanical engineering from the National Technical University of Athens, and his masters degree in mechanical engineering from the Technical University of Munich in 2006. From 2006-2007 he was a graduate research assistant at the Ultrasound Elasticity laboratory (Prof. Elisa Konofagou) in the Department of Biomedical Engineering, Columbia University, New York. Dr. Zervantonakis completed his doctoral studies at MIT in the mechanobiology laboratory (Prof. Roger Kamm) in the Department of Mechanical Engineering in December 2012. Since January 2013 he has been a postdoctoral fellow in cancer biology at Harvard Medical School in the lab of Prof. Joan Brugge and has been awarded the DoD Breast Cancer Postdoctoral Fellowship.

Ioannis Zervantonakis Image

Controlled Drug Release and Cell Response with a 3D Acoustofluidic Tumor Model

Friday, 8 July 2016 at 16:00

Add to Calendar ▼2016-07-08 16:00:002016-07-08 17:00:00Europe/LondonControlled Drug Release and Cell Response with a 3D Acoustofluidic Tumor ModelSELECTBIOenquiries@selectbiosciences.com

We developed a novel acoustofluidic platform by integrating a physiologically relevant 3D microfluidic device and a FUS system with a closed-loop controller to study drug transport and assess the response of cancer cells to chemotherapy in real time using live cell microscopy. Our 3D platform enables the accurate control of the drug-release area in order to establish chemotherapeutic agent concentration gradients in a physiologically relevant environment. This acoustofluidic platform that can aid the discovery of new therapeutic protocols for non-invasive cancer treatments that target tumor cells regionally without damaging adjacent normal cells.

Add to Calendar ▼2016-07-07 00:00:002016-07-08 00:00:00Europe/LondonOrgan-on-a-Chip and Body-on-a-Chip: In Vitro Systems Mimicking In Vivo FunctionsSELECTBIOenquiries@selectbiosciences.com


Corporate Sponsors